Thursday, August 25, 2016 1:17:31 PM
So, for me, and me alone, the issue falls to intent. I say BIEL management is clean on that; were shareholders disadvantaged, not that I can determine. Seems to me there is a huge burden of proof that there was a gain by anyone.
In fact, I thought the financing model was highly creative, sound, viable and, in fact, financed the company openly, successfully, with full prior disclosure to shareholders as to goals, methodology, intent and results, and with zero harm to anyone.
Anyone screaming at you and me that the Whelans advantaged themselves financially firstly doesn't know the Whelans and, secondly, has no clue as to their lifestyle. I will wager a lot of money that BIEL can account for every dollar raised and that there was no impropriety.
You and I are reasonably smart fellows, as are most readers here; when anyone screams and misleads that there was criminal advantage, all we have to do is demand they prove it. The absence of one iota of proof will make all the yelling false allegations, white sound and meaningless. If SEC staffers and senior excuse are smart, they are using ActiPatch and buying shares . . . . BIEL Double Tsunami . . . . .soon.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM